{"id":4108,"date":"2021-04-12T06:00:00","date_gmt":"2021-04-12T06:00:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/"},"modified":"2021-04-12T06:00:00","modified_gmt":"2021-04-12T06:00:00","slug":"covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/","title":{"rendered":"Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien"},"content":{"rendered":"
\n

Den planerade starten av Nanexas fas I-studie i NEX-18-projektet var satt till den 15 april. Kliniken p\u00e5 Akademiska sjukhuset meddelade Nanexa p\u00e5 fredagen att de beh\u00f6ver l\u00e5na ut sin personal till Covidv\u00e5rd och d\u00e4rf\u00f6r inte kan starta studien som planerat den 15:e. Bolaget och kliniken st\u00e5r i n\u00e4ra kontakt med varandra f\u00f6r att hitta en s\u00e5 snabb l\u00f6sning som m\u00f6jligt. P\u00e5 Nanexas andra pr\u00f6varsite p\u00e5 Karolinska Universitetssjukhuset i Huddinge p\u00e5g\u00e5r f\u00f6rberedelserna f\u00f6r fullt och d\u00e4r ber\u00e4knas studien kunna starta enligt fastlagd plan i slutet av april.<\/strong><\/p>\n<\/div>\n

\n

\u201dDet \u00e4r klart att vi helst skulle vilja ha startat studien i b\u00e5de Uppsala och Huddinge enligt plan. Samtidigt har vi full f\u00f6rst\u00e5else f\u00f6r prioriteringen som Akademiska beh\u00f6ver g\u00f6ra till f\u00f6rm\u00e5n f\u00f6r Covidv\u00e5rd. Det \u00e4r inget tvivel om det. Vi diskuterar nu om Huddinge ist\u00e4llet kan ta en st\u00f6rre del av studien. Om denna f\u00f6rsening p\u00e5verkar n\u00e4r vi f\u00e5r slutligt resultat \u00e4r f\u00f6r tidigt att s\u00e4ga i dessa os\u00e4kra tider. Vi har ett mycket bra samarbete med b\u00e4gge klinikerna och vet att de kommer g\u00f6ra allt f\u00f6r att genomf\u00f6ra studien s\u00e5 snart och snabbt som m\u00f6jligt\u201d, s\u00e4ger Nanexas vd David Westberg.
\u00a0<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag fokuserat p\u00e5 utvecklingen av PharmaShell\u00ae, ett nytt och banbrytande drug delivery-system med stor\u00a0potential inom ett flertal substanstyper och indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae utvecklar Nanexa egna projekt och har samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland\u00a0AstraZeneca.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Den planerade starten av Nanexas fas I-studie i NEX-18-projektet var satt till den 15 april. Kliniken p\u00e5 Akademiska sjukhuset meddelade Nanexa p\u00e5 fredagen att de beh\u00f6ver l\u00e5na ut sin personal till Covidv\u00e5rd och d\u00e4rf\u00f6r inte kan starta studien som planerat den 15:e. Bolaget och kliniken st\u00e5r i n\u00e4ra kontakt med varandra f\u00f6r att hitta en s\u00e5 snabb l\u00f6sning som m\u00f6jligt. P\u00e5 Nanexas andra pr\u00f6varsite p\u00e5 Karolinska Universitetssjukhuset i Huddinge p\u00e5g\u00e5r f\u00f6rberedelserna f\u00f6r fullt och d\u00e4r ber\u00e4knas studien kunna starta enligt fastlagd plan i slutet av april.<\/p>\n","protected":false},"template":"","class_list":["post-4108","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nCovidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Den planerade starten av Nanexas fas I-studie i NEX-18-projektet var satt till den 15 april. Kliniken p\u00e5 Akademiska sjukhuset meddelade Nanexa p\u00e5 fredagen att de beh\u00f6ver l\u00e5na ut sin personal till Covidv\u00e5rd och d\u00e4rf\u00f6r inte kan starta studien som planerat den 15:e. Bolaget och kliniken st\u00e5r i n\u00e4ra kontakt med varandra f\u00f6r att hitta en s\u00e5 snabb l\u00f6sning som m\u00f6jligt. P\u00e5 Nanexas andra pr\u00f6varsite p\u00e5 Karolinska Universitetssjukhuset i Huddinge p\u00e5g\u00e5r f\u00f6rberedelserna f\u00f6r fullt och d\u00e4r ber\u00e4knas studien kunna starta enligt fastlagd plan i slutet av april.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\\\/\",\"name\":\"Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2021-04-12T06:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/","og_locale":"sv_SE","og_type":"article","og_title":"Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien - Nanexa AB","og_description":"Den planerade starten av Nanexas fas I-studie i NEX-18-projektet var satt till den 15 april. Kliniken p\u00e5 Akademiska sjukhuset meddelade Nanexa p\u00e5 fredagen att de beh\u00f6ver l\u00e5na ut sin personal till Covidv\u00e5rd och d\u00e4rf\u00f6r inte kan starta studien som planerat den 15:e. Bolaget och kliniken st\u00e5r i n\u00e4ra kontakt med varandra f\u00f6r att hitta en s\u00e5 snabb l\u00f6sning som m\u00f6jligt. P\u00e5 Nanexas andra pr\u00f6varsite p\u00e5 Karolinska Universitetssjukhuset i Huddinge p\u00e5g\u00e5r f\u00f6rberedelserna f\u00f6r fullt och d\u00e4r ber\u00e4knas studien kunna starta enligt fastlagd plan i slutet av april.","og_url":"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/","url":"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/","name":"Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2021-04-12T06:00:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/covidsituationen-pa-akademiska-sjukhuset-i-uppsala-paverkar-start-av-nex-18-fas-ia-studien\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Covidsituationen p\u00e5 Akademiska sjukhuset i Uppsala p\u00e5verkar start av NEX-18 fas Ia-studien"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/4108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=4108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}